Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 16: 235-238, 1970;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobkirk, R.
Right arrow Articles by Blahey, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobkirk, R.
Right arrow Articles by Blahey, P. R.

Clinical Chemistry, Vol 16, 235-238, Copyright © 1970 by the American Association for Clinical Chemistry

Contribution of Estriol to Total Urinary Estrogens during Pregnancy

R. Hobkirk 1, Y. Anuman-Rajadhon 1, M. Nilsen 1, and P. R. Blahey 1

1 McGill University Medical Clinic, The Montreal General Hospital, and Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

Estriol accounts for an average of 74% of the principal Kober-positive steroids in the urine of 13 women during uncomplicated pregnancies. This proportion is independent of the stage of pregnancy, from 20 weeks until term. The average ratio of estriol to ring-D agr-ketols (mainly 16agr-hydroxyestrone and 16-ketoestradiol-17beta) is about 5:1 over the same period. In 17 pregnant women with diabetes, urinary estriol averaged 63% of the "total steroids" during a similar period, and the average ratio of estriol to ring-D agr-ketols was 3:1. The quantitative importance of these ketolic steroids may introduce a problem in deciding whether to measure estriol or "total estrogens" when evaluating fetal viability in complicated pregnancies.

Submitted on February 18, 1969
Accepted on March 19, 1969







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Association for Clinical Chemistry.